Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Simple Search

Search Type: Criteria:

You could also try: dot (14), spot (88), point (473), stop (1000)

AmsacrineCytarabineEtoposide_MACE

Description: Chemotherapy Protocol ACUTE MYELOID LEUKAEMIA AMSACRINE-CYTARABINE-ETOPOSIDE In-Patient Regimen Regimen • Acute Myeloid Leukaemia – InP-Amsacrine-Cyta
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/AmsacrineCytarabineEtoposide-MACE.pdf

Topotecan (1,8,15)

Description: Chemotherapy Protocol GYNAECOLOGICAL CANCER TOPOTECAN INTRAVENOUS (1, 8, 15) Regimen Ovary – Topotecan (1, 8, 15) Indication Second-line or su
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/Topotecan1815.pdf

Topotecan (1,8)

Description: Chemotherapy Protocol GYNAECOLOGICAL CANCER TOPOTECAN INTRAVENOUS (1, 8) Regimen Ovary – Topotecan (1, 8) Indication Second-line or subsequent
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/Topotecan18.pdf

Topotecan (1,2,3,4,5)

Description: Chemotherapy Protocol GYNAECOLOGICAL CANCER TOPOTECAN INTRAVENOUS (1, 2, 3, 4, 5) Regimen Ovary – Topotecan (1, 2, 3, 4, 5) Indication Second-
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/Topotecan12345.pdf

Etoposide PO

Description: Chemotherapy Protocol GYNAECOLOGICAL CANCER ETOPOSIDE ORAL Regimen Ovary-Etoposide Oral Indication Second line or subsequent treatment of recurrent platinum
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/EtoposidePO.pdf

Carboplatin(AUC5)-Paclitaxel (21 day)

Description: Chemotherapy Protocol GYNAECOLOGICAL CANCER CARBOPLATIN (AUC5)-PACLITAXEL 21 day Regimen • Ovary-Carboplatin (AUC5)-Paclitaxel (21 day) Indicatio
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/CarboplatinAUC5-Paclitaxel21day.pdf

Carboplatin(AUC5)-Paclitaxel (21 day)

Description: Chemotherapy Protocol GYNAECOLOGICAL CANCER CARBOPLATIN (AUC5)-PACLITAXEL (21 day) Regimen • Uterine-Carboplatin (AUC5)-Paclitaxel (21 day) Indic
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Uterine-cancer/CarboplatinAUC5-Paclitaxel21day.pdf

Raltitrexed Ver 1.2

Description: Chemotherapy Protocol COLORECTAL CANCER Regimen RALTITREXED Colorectal Cancer– Raltitrexed Indication Treatment of metastatic / advanced colorectal
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/RaltitrexedVer12.pdf

Panitumumab (21 day) Ver 1.1

Description: Chemotherapy Protocol COLORECTAL CANCER PANITUMUMAB (21 day) This regimen may require funding and is an unlicensed dose Regimen Colorectal Cancer
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Panitumumab21dayVer11.pdf

ColorectalTrifluridineTipiricilVer1

Description: Chemotherapy Protocol Regimen COLORECTAL CANCER TRIFLURIDINE-TIPIRACIL  Colorectal Cancer – Trifluridine-Tipiracil Indication  Trifluridine-tipi
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/ColorectalTrifluridineTipiricilVer1.pdf

351 to 360 of 680

Previous … 34 35 36 37 38 … Next